NYSE - Nasdaq Real Time Price USD

GSK plc (GSK)

Compare
43.91 +0.17 (+0.39%)
At close: August 30 at 4:00 PM EDT
43.62 -0.29 (-0.66%)
Pre-Market: 6:55 AM EDT
Loading Chart for GSK
DELL
  • Previous Close 43.74
  • Open 43.75
  • Bid 43.59 x 800
  • Ask 43.71 x 1100
  • Day's Range 43.54 - 43.98
  • 52 Week Range 33.67 - 45.93
  • Volume 3,129,062
  • Avg. Volume 3,536,935
  • Market Cap (intraday) 89.553B
  • Beta (5Y Monthly) 0.31
  • PE Ratio (TTM) 14.73
  • EPS (TTM) 2.98
  • Earnings Date Oct 30, 2024
  • Forward Dividend & Yield 1.53 (3.49%)
  • Ex-Dividend Date Aug 16, 2024
  • 1y Target Est 46.07

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

www.gsk.com

70,212

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GSK

View More

Performance Overview: GSK

Trailing total returns as of 9/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GSK
21.77%
FTSE 100
7.62%

1-Year Return

GSK
30.11%
FTSE 100
11.49%

3-Year Return

GSK
19.84%
FTSE 100
16.17%

5-Year Return

GSK
32.52%
FTSE 100
14.29%

Compare To: GSK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GSK

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    88.98B

  • Enterprise Value

    107.35B

  • Trailing P/E

    14.75

  • Forward P/E

    10.38

  • PEG Ratio (5yr expected)

    1.53

  • Price/Sales (ttm)

    1.91

  • Price/Book (mrq)

    4.72

  • Enterprise Value/Revenue

    2.59

  • Enterprise Value/EBITDA

    10.08

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.83%

  • Return on Assets (ttm)

    9.56%

  • Return on Equity (ttm)

    33.30%

  • Revenue (ttm)

    31.45B

  • Net Income Avi to Common (ttm)

    4.03B

  • Diluted EPS (ttm)

    2.98

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.98B

  • Total Debt/Equity (mrq)

    123.04%

  • Levered Free Cash Flow (ttm)

    5.5B

Research Analysis: GSK

View More

Company Insights: GSK

Research Reports: GSK

View More

People Also Watch